Autonomic neuropathy is a frequent complication of long standing diabetes mellitus.12 Clinically autonomic neuropathy is well known to produce symptoms caused by cardiovascular dysfunction and cardiovascular reflexes are used to diagnose autonomic neuropathy.34 The gastrointestinal tract, however, is another area that may become severely affected by autonomic neuropathy. The prevalence of symptoms caused by gastrointestinal dysfunction may reach 76% in an unselected population of diabetic outpatients. 5 Delayed gastric emptying as a result of gastroparesis is probably the best known and most extensively evaluated motor disturbance of the gastrointestinal tract in diabetic patients. Other parts of the digestive system may, however, also be affected and *in a number of different studies constipation and diarrhoea as well as impaired gall bladder contraction in diabetic patients have been attributed to autonomic neuropathy.7 -" Despite these many reports, a comprehensive evaluation of the motor function at different levels of the gastrointestinal tract in diabetic patients has never been carried out. Thus, in the present study we have evaluated gastric clearance of indigestible markers, orocaecal transit time, colonic transit time, and gall bladder contraction in two groups of diabetic patients who differed as to whether they had or did not have signs of autonomic neuropathy affecting the cardiovascular system.
Methods

PATIENTS
Diabetic patients attending our outpatient clinic were evaluated for participation in this study. Patients were selected on a random, consecutive basis. They were asked to participate only if they had no history of gastrointestinal diseases or abdominal surgery other than appendectomy, and if they had no symptoms that could be attributed to gastrointestinal motility disorders. Twenty six patients in whom the presence or absence of autonomic neuropathy affecting the cardiovascular system was established participated in this study. The study protocol was approved by the Human Ethical Committee of the University of Basel and written informed consent was obtained from each subject. Clinical data of the patients studied are given in Table I. ASSESSMENT OF other pathology were identified in any subject. Gall bladder volumes were calculated from the measured parameters with the software of the ultrasound unit, assuming that the shape of the gall bladder approximated a solid with elliptical sections, the excentricity depending on that at the level of the greatest transverse section. These assumptions and the mathematical formula used to calculate the volume have been described and validated by Everson and colleagues. 19 All patients were studied after overnight fasting. After a basal period of 30 minutes, increasing doses of synthetic cholecystokinin octapeptide (CCK8) were infused intravenously, each dose for 30 minutes (2-4, 7.2, 21.6 pmol/kg/ hour). Every 10 minutes, three images of the gall bladder were taken and the mean of the three measurements was taken as the response at this time point.
Gastric clearance ofindigestible markers Gastric emptying was assessed on a different day after overnight fasting by means of 10 radioopaque markers ingested with a standard test meal.'8 These markers were custom made polyurethane particles impregnated with barium sulphate, of density 1-7 g/ml, measuring 2 x 2 x 10 mm. Radiographs of the upper abdomen (24x 30 cm) were taken 1.5, 3, 4 5, and 6 hours after a meal and marker ingestion by high voltage technique (100 kV, 20 mAs) to minimise radiation exposure. Two observers independently assessed the films to count the number of markers retained in the stomach. If all markers had passed from the stomach in less than six hours, subsequent radiographs were not taken. The test meal consisted of 10 radioopaque markers, orange juice, crunchy nut cornflakes, 100 ml milk, and biscuits with cheese amounting to a total of 69.5 g carbohydrates, 10 .4 g fat, and 7.8 g protein (413 kcal). Twenty minutes before ingestion of the meal, the usual insulin dose was administered by the patients. The 
Results
Twenty six diabetic patients, of whom 22 were insulin dependent and four non-insulindependent (Table I) , were studied. Eleven of these patients had signs of autonomic neuropathy affecting the cardiovascular system and in 15 patients there were no signs of autonomic cardiovascular dysfunction. The two patient groups did not differ with respect to age and gender, but there were significant differences as to mean Hb A1C levels, in duration of diabetes and the presence of retinopathy (Table I) .
GALL BLADDER CONTRACTION
Mean fasting gall bladder volumes were similar in the two patient groups (17-2 (2.8) ml in patients with cardiovascular autonomic neuro- cc pathy and 17.9 (1-6) ml in patients without). Intravenous infusion of graded doses of cholecystokinin 8 induced a dose dependent and significant decrease in gall bladder volume in bothgroups of patients. Gall bladder contraction was significantly (p<0-05) weaker, however, in patients with cardiovascular autonomic neuropathy as compared with those without (Fig 1) Colonic transit time was significantly longer in the patients with cardiovascular autonomic neuropathy. This resulted from slower regional transit through all three parts of the colon, although the difference was significant for the right colon only. These findings agree with a previous study of diabetic neuropathy where constipation was the most common gastrointestinal symptom.7 It has to be pointed out, however, that we selected asymptomatic patients and thus total colonic transit times have still to be considered in the high normal range.
The present study confirmed and extended previous observations that different gut motor functions can be impaired in diabetic patients with cardiovascular autonomic neuropathy. We did not find a correlation between disturbed gastric emptying, impaired gall bladder contraction, and prolonged colonic transit time in the patients with cardiovascular autonomic neuropathy; also, there was no correlation between any disturbed motor function and age or longstanding history of diabetes. These findings support the hypothesis that autonomic neuropathy affects-motility throughout the gastrointestinal tract. Any disturbed motor function in the gut could therefore be one of the numerous expressions of diabetic neuropathy which can affect the cardiovascular, the endocrine or the gastrointestinal system. The lack of correlation between the four motility parameters furthermore implies that the disturbed motor functions develop independently and can affect any gut system. From our results one could speculate that impairment of gall bladder contraction is a sensitive parameter for the diagnosis of autonomic neuropathy in the gastrointestinal tract.
Such a hypothesis requires, however, confirmation in a large group of patients. 
